A number of reports have shown increased expression of AR in human CRPC tissues based on gene expression [21–35] and immunohistochemistry [31,32] as well as circulating tumor cells from CRPC patients [17,36–38], although inconsistent results have been reported for a significant association between high AR expression and clinical outcomes [26,31,34]. The gene discussed is AR; the disease is neoplasm.